Literature DB >> 33946383

Trends in Prevalence of Diabetes among Twin Pregnancies and Perinatal Outcomes in Catalonia between 2006 and 2015: The DIAGESTCAT Study.

Lucia Gortazar1,2, Juana Antonia Flores-Le Roux1,2,3, David Benaiges1,2,3,4, Eugènia Sarsanedas5, Humberto Navarro1,2, Antonio Payà6, Laura Mañé1,2, Juan Pedro-Botet1,2,3, Albert Goday1,2,3.   

Abstract

The aims of our study were to evaluate the trends in the prevalence of diabetes among twin pregnancies in Catalonia, Spain between 2006 and 2015, to assess the influence of diabetes on perinatal outcomes of twin gestations and to ascertain the interaction between twin pregnancies and glycaemic status. A population-based study was conducted using the Spanish Minimum Basic Data Set. Cases of gestational diabetes mellitus (GDM) and pre-existing diabetes were identified using ICD-9-CM codes. Data from 743,762 singleton and 15,956 twin deliveries between 2006 and 2015 in Catalonia was analysed. Among twin pregnancies, 1088 (6.82%) were diagnosed with GDM and 83 (0.52%) had pre-existing diabetes. The prevalence of GDM among twin pregnancies increased from 6.01% in 2006 to 8.48% in 2015 (p < 0.001) and the prevalence of pre-existing diabetes remained stable (from 0.46% to 0.27%, p = 0.416). The risk of pre-eclampsia was higher in pre-existing diabetes (15.66%, p = 0.015) and GDM (11.39%, p < 0.001) than in normoglycaemic twin pregnancies (7.55%). Pre-existing diabetes increased the risk of prematurity (69.62% vs. 51.84%, p = 0.002) and large-for-gestational-age (LGA) infants (20.9% vs. 11.6%, p = 0.001) in twin gestations. An attenuating effect on several adverse perinatal outcomes was found between twin pregnancies and the presence of GDM and pre-existing diabetes. As a result, unlike in singleton pregnancies, diabetes did not increase the risk of all perinatal outcomes in twins and the effect of pre-existing diabetes on pre-eclampsia and LGA appeared to be attenuated. In conclusion, prevalence of GDM among twin pregnancies increased over the study period. Diabetes was associated with a higher risk of pre-eclampsia, prematurity and LGA in twin gestations. However, the impact of both, pre-existing diabetes and GDM, on twin pregnancy outcomes was attenuated when compared with its impact on singleton gestations.

Entities:  

Keywords:  epidemiology; gestational diabetes; perinatal outcomes; pre-existing diabetes; prevalence; trends; twins

Year:  2021        PMID: 33946383     DOI: 10.3390/jcm10091937

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  35 in total

Review 1.  Epidemiology of twinning in developed countries.

Authors:  Cande V Ananth; Suneet P Chauhan
Journal:  Semin Perinatol       Date:  2012-06       Impact factor: 3.300

2.  Increased levels and pulsatility of follicle-stimulating hormone in mothers of hereditary dizygotic twins.

Authors:  C B Lambalk; D I Boomsma; L De Boer; C H De Koning; E Schoute; C Popp-Snijders; J Schoemaker
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Risk for gestational diabetes and hypertension for women with twin pregnancy compared to singleton pregnancy.

Authors:  Kai J Buhling; Wolfgang Henrich; Elizabeth Starr; Marion Lubke; Silke Bertram; Gerda Siebert; Joachim W Dudenhausen
Journal:  Arch Gynecol Obstet       Date:  2003-04-02       Impact factor: 2.344

4.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

Authors:  Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2005-06-12       Impact factor: 91.245

Review 5.  Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review.

Authors:  B S Buckley; J Harreiter; P Damm; R Corcoy; A Chico; D Simmons; A Vellinga; F Dunne
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

6.  Risk for developing gestational diabetes in women with twin pregnancies.

Authors:  Jose A Rauh-Hain; Sarosh Rana; Hector Tamez; Alice Wang; Bruce Cohen; Allison Cohen; Florence Brown; Jeffrey L Ecker; S Ananth Karumanchi; Ravi Thadhani
Journal:  J Matern Fetal Neonatal Med       Date:  2009-04

7.  Twin pregnancies complicated by gestational diabetes mellitus: a single centre cohort study.

Authors:  G K Dinham; A Henry; S A Lowe; N Nassar; K Lui; V Spear; A W Shand
Journal:  Diabet Med       Date:  2016-02-22       Impact factor: 4.359

8.  Gestational diabetes mellitus is associated with adverse outcomes in twin pregnancies.

Authors:  Liran Hiersch; Howard Berger; Rania Okby; Joel G Ray; Michael Geary; Sarah D McDonald; Beth Murray-Davis; Catherine Riddell; Ilana Halperin; Haroon Hasan; Jon Barrett; Nir Melamed
Journal:  Am J Obstet Gynecol       Date:  2018-10-25       Impact factor: 8.661

9.  Diabetes and pregnancy: national trends over a 15 year period.

Authors:  Sharon T Mackin; Scott M Nelson; Joannes J Kerssens; Rachael Wood; Sarah Wild; Helen M Colhoun; Graham P Leese; Sam Philip; Robert S Lindsay
Journal:  Diabetologia       Date:  2018-01-11       Impact factor: 10.122

10.  Trends in prevalence of pre-existing diabetes and perinatal outcomes: a large, population-based study in Catalonia, Spain, 2006-2015.

Authors:  Lucia Gortazar; Albert Goday; Juana Antonia Flores-Le Roux; Eugènia Sarsanedas; Antonio Payà; Laura Mañé; Juan Pedro-Botet; David Benaiges
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
View more
  3 in total

1.  Perinatal outcomes of twin pregnancies with preterm premature rupture of the membranes at 24-34 weeks' gestation.

Authors:  Shuwei Zhou; Yajun Yang; XiaoYan Zhang; Xiaoling Mu; Quan Quan; Qimei Zhong; Lingwei Mei; Lan Wang
Journal:  Sci Rep       Date:  2021-12-03       Impact factor: 4.379

Review 2.  Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors.

Authors:  Ying Yang; Na Wu
Journal:  Front Cardiovasc Med       Date:  2022-02-16

3.  Recent Advances in Gestational Diabetes Mellitus.

Authors:  Katrien Benhalima
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.